First FDA clearance for a next-gen BCI array
2025-04Precision Neuroscience
The Layer 7 cortical interface (1,024 electrodes) got 510(k) clearance — a regulatory first for the new wave.
All actors 
View this company against market data on FM Invest
Precision Neuroscience
Profile
Surface Layer 7 cortical interface (1,024 electrodes, reversible); first next-gen BCI to win FDA clearance, 2025.
Editorial profile — compiled by us from public sources.
- Founded
- 2021
- Headquarters
- New York, NY, US
- Funding raised
- $155M
Current standings
Standings and milestones are always verified by us against primary sources, regardless of who manages the profile.
